Target intelligence / Profile preview

Serine beta-Lactamase (Class A)

Molecular classification
Enzyme, Hydrolase
01

Overview

Serine beta-lactamases (class A) are enzymes produced by bacteria that confer resistance to beta-lactam antibiotics, such as penicillins and cephalosporins, by hydrolyzing the characteristic beta-lactam ring of these drugs. This enzymatic activity renders the antibiotics ineffective, allowing bacteria to survive in their presence. The catalytic process involves two main steps: acylation and deacylation. Notable examples include TEM-1, SHV, CTX-M, and KPC-type enzymes. These enzymes are major contributors to bacterial resistance against widely used antibiotics. They are found predominantly in Gram-negative bacteria but also occur in some Gram-positive species like staphylococci. Class A serine β-lactamases can often be inhibited by compounds such as clavulanic acid or tazobactam; however, some variants show reduced susceptibility or resistance even to these inhibitors.

Other names
Class A beta-lactamaseClass A serine beta-lactamase
02

Mechanism of action

Acylation–deacylation via nucleophilic attack on β-lactam ring

03

Biological functions

Hydrolysis of beta-lactam antibioticsDrug resistance
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Development of resistanceReduced susceptibility to beta-lactamase inhibitors
06

Interacting drugs

Penicillins

4 more in the full profile.

Beyond the preview

Go deeper on Serine beta-Lactamase (Class A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine beta-Lactamase (Class A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call